Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Earnings Winners & Losers: QGEN, WMGI, ALR, SN, and LIVN

Executive Summary

Diagnostics, orthopedics, and cardiovascular device companies are among those that wait until November to report their results for the quarter that ended at the end of September. Medtech Insight’s Earnings Winners & Losers highlights some of the companies that had news to celebrate, and a few that were disappointed with the quarter.

You may also be interested in...



MTI 100: The Rise And Fall Of Medtech's Giants

The global medtech industry has a new leader, after a bulked-up Medtronic knocked Johnson & Johnson off its throne. But astute M&A deals, as well as divestments and knock-on impact from poor sales and negative currency effects, have also led to other movements in the medtech company rankings. Medtech Insight's 2016 edition of its annual league tables – MTI 100 and the Top 10 sector leaders – show who's climbed up and who's slipped down.

Starts & Stops: Respicardia Puts Sleep Apnea Device PAS On Snooze

Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial initiations, completions and suspensions over the past month. This edition takes a closer look at Respicardia, which has cut short the post-approval study of its implantable sleep apnea device study.

Earnings Winners & Losers: BSX, BCR, EW, PHG, SYK, TFX, TMO

The earnings season is now in full swing with more large-cap medtech stocks releasing their quarterly results. This week we spotlight cardiology market leaders Boston Scientific and Edwards Lifesciences, big ortho hitter Stryker, specialty diagnostics provider Thermo Fisher, and diversified players such as Philips, Bard and Teleflex. But which among them are this season's earnings winners and losers?

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT104081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel